Abstract. Penicillin-binding proteins (PBPs) are membrane proteins involved in the final stages of peptidoglycan synthesis and represent the targets of b-lactam antibiotics. Enterococci are naturally resistant to these antibiotics because they produce a PBP, named PBP5fm in Enterococcus faecium, with low-level affinity for b-lactams. We report here the crystal structure of the acyl-enzyme complex of PBP5fm with benzylpenicillin at a resolution of 2.4 Å. A characteristic of the active site, which distinguishes PBP5fm from other PBPs of known structure, is the topology of the loop 451 -465 defining the left CMLS, Cell. Mol. Life Sci. 59 (2002) 
transglycosylase activity. HMM-PBPs are further divided into classes A and B according to their function and the sequence similarities found in their non-penicillin-binding module [3, 4] . The penicillin-binding module of the multimodular PBPs is associated with at least one other domain which is assumed to have a transglycosylase activity in class A HMM-PBPs. The role of the non-penicillin-binding domain of class B HMM-PBPs is not yet understood. Transglycosylase activity has not been detected in this class of PBPs and the non-penicillin-binding module has been proposed to interact with other proteins to form multiprotein complexes [5 -7] . Enterococci, which are involved in many nosocomial infections, are naturally resistant to b-lactam antibiotics. Furthermore, they have become increasingly resistant to many antibiotics and are thus responsible for an increasing number of therapeutic failures [8 -10] . Enterococcus faecium is the most penicillin resistant enterococcal species, with MICs ranging from 0.5 to more than 64 mg/ml for clinical isolates. MICs as high as 256 and 512 mg/ml have been found in very resistant strains [11, 12] . Some highly blactam resistant E. faecium strains are also vancomycin resistant [12 -14] , although vancomycin and b-lactam antibiotics can act in a synergistic way against vancomycinresistant enterococci [15] . Since ampicillin resistance and vancomycin-vanB-type resistance have recently been shown to be cotransferable within a large mobile element [14 -16] , this double resistance has become a serious public health problem. The natural resistance of enterococci to b-lactam antibiotics is due to the presence of one PBP (named PBP5fm in E. faecium) with low-level affinity for penicillin. Resistance to b-lactam in E. faecium may be enhanced by higher levels of PBP5fm production. However, overproduction is not the only path to resistance within resistant strains of E. faecium. Point mutations in the PBP5fm further reduce the affinity of the protein for b-lactams, leading to very high levels of resistance [13, 17] . PBP5fm is thought to be able to take over the role of the other HMMPBPs in peptidoglycan synthesis when these proteins are inhibited by an antibiotic [10, 11, 18, 19] . In E. faecalis, the peptidoglycan synthesized by PBP5 in the presence of benzylpenicillin is slightly different from that produced by the usual PBPs in the absence of benzylpenicillin. The main differences are the lack of oligomers higher than tetramers and a reduction in the number of tetramers in the muropeptide composition of the peptidoglycan, suggesting that PBP5 is unable to use trimeric peptides as donors or acceptors in transpeptidase reactions to form oligomeric cross-linked muropeptides. Nevertheless, under these conditions, PBP5 still cross-links the unmodified peptidoglycan pentapeptide precursors [20] . In contrast, strains showing vancomycin resistance are now assumed to synthesize a pentapeptide with an abnormal carboxyterminal unable to bind vancomycin. The syner- [24] , resistance to b-lactams is a constitutive element of E. faecium and a few point mutations in PBP5fm can lead to very high levels of resistance.
Materials and methods
Construction and expression of recombinant PBP5fm molecules DNA encoding PBP5fm was amplified by PCR using pDML517 [12] as template and primers designed to introduce NcoI and NdeI cloning sites, to replace the hydrophobic anchoring peptide and putative polar region by a Met-Gly peptide in positions 32 and 33 and to introduce a Leu-Glu dipeptide at the C terminal end of the protein.
The PCR product was first cloned into a pUC18 derivative generating pDML536 and subcloned in the pET28a expression vector generating pDML537. The recombinant protein was overproduced at 25°C in the cytoplasm of Escherichia coli BL21 (DE3) cells that were grown in medium containing kanamycin (50 mg/l) by a fed-batch process [25] . To obtain a selenium-labeled PBP5fm derivative, the pDML537 insert was subcloned into NcoI and EcoRI restriction sites of the pTRC99a expression vector. The labeled recombinant protein was overproduced at 33°C in the cytoplasm of methionine-auxotrophic E. coli b180 cells that were grown in a medium containing Se-methionine (200 mg/l) [26] .
Purification and crystallization
IPTG-induced cells were sonicated (15 min -1 ) and centrifuged to discard cell debris. Both PBP5fm forms were purified by anion exchange (Q-sepharose HP and Qsepharose Hitrap), hydroxyapatite (ceramic-hydroxyapatite type I) and gel filtration (Superdex 200 pf) chromatography to reach an approximate 95 % purity. Several crystals were obtained from the purified native protein and its selenium-labeled derivative, at various protein concentrations ranging from 5 to 90 mg/ml. All crystals were grown by the sitting-drop vapor diffusion method. For the crystal leading to the structure determination, the purified seleno-methionine-labeled PBP5fm protein was concentrated and cocrystallized with benzylpenicillin by mixing at the ratio 1:5. The crystal was grown at 20°C by mixing equal volumes of PBP5fm (15 mg/ml), 10 % PEG8000 (w/v), 0.4 M Li 2 SO 4 and 100 mM Na acetate at pH 4.5. The crystal appeared within 1 week and reached its maximum size (0.300 ¥ 0.15 ¥ 0.10 mm) in about 2 weeks.
Data collection, phase determination and structure refinement
The crystal was cryoprotected in the same buffer containing 20 % (v/v) glycerol and flash-cooled at 100 K for data collection at the ID14-eh4 beamline (European Synchrotron Radiation Facility-ESRF, Grenoble) using an ADSC Quantum 4RCCD detector. MAD data were collected at three different wavelengths (Se-peak, inflection, remote). At each wavelength, 540 frames were collected with an exposure time of 0.5 s and an oscillation of one-third of a degree. The three data sets were complete up to 2.4 Å (statistics are given in table 1). The crystal belongs to the space group C2 (a = 79.3 Å, b = 128.8 Å, c = 236.1 Å and b = 93.92°) with three molecules in the asymmetric unit. Integration was performed with MOSFLM [27] and scaling with the program SCALA from the CCP4 program suite [28] . PBP5fm is a 648-amino-acid protein with 13 methionines. Thirty out of the 39 possible selenium sites were localized using SHAKE-AND-BAKE [29] and coordinates further refined by use of the MLPHARE program from the CCP4 suite. The multiwavelength anomalous diffraction method (MAD) map calculated after density modification with DM [30] was suitable for initiating the protein construction. The major part of the C-terminal and the N-terminal domain (without residues 193 -256) were built in the MAD map using TURBO-FRODO [31] . Simulating annealing with CNS [32] and manual rebuilding allowed completion of the model except residues 32 -38, 193 -256 and 623 -632. The three monomers were refined individually. The Ramachandran plot analysis revealed that 84.4 % of the non-proline, non-glycine residues are in the most favored region, and 14.7 % are in the additionally allowed region.
Results

Structure of PBP5fm
The crystal structure of PBP5fm was solved at 2.4 Å by MAD using data collected from one crystal of the SeMet-substituted protein cocrystallized in the presence of benzylpenicillin. The space group is C2 with three molecules in the asymmetric unit. The structure was refined against the data set collected at the remote wavelength with an R-factor of 22.7 % and an R free of 28.6 %. The final model contains 570 residues per monomer and one benzylpenicillin molecule bound to the active-site serine of each monomer. PBP5fm presents two clear distinct domains ( fig. 1 ), the N-and the C-terminal domain, the latter being the transpeptidase domain that shows weak penicillin-binding activity. The N-terminal domain exhibits a new type of folding. The N-terminal helix begins at residue 39, residues 33 -38 being invisible in the electron density map. The region up to residue 162 is globular and composed of two helices (a N1 and a N2 ) and a three-stranded antiparallel b sheet (b N1 to b N3 ). A long b sheet connects this globular domain to the C-terminal domain. It is comprised of the strands b N5 , b N10 and b N11 that form a three-stranded antiparallel b sheet on the N-terminal side and becomes a two-stranded parallel b sheet (segments 170 -177 and 337 -344) on the C-terminal side. In the central region (residues 190 -260), the electron density maps only suggest some secondary-structure elements that were not included in the final model. Its conformation must differ from the equivalent PBP2x region since there would be a steric clash between this region and a symmetrical protein in the crystal packing. An attempt to determine the backbone trace in monomer A is shown in figure 1 B.
The N-terminal domain has been shown to be important for the folding of the PBP5 enzyme from E. hirae, the sequence of which is nearly identical to that of PBP5fm [33] . The deletion of some segments in the N-terminal domain resulted in proteins unable to bind penicillin, a situation that also prevails in E. coli PBP3 [5] and S. aureus PBP2a [34] . Transglycosylase activity has not been demonstrated in PBP5fm and no clear biological function could be attributed to the N-terminal domain, which could, according to the most widely accepted assumptions, interact with other proteins to form a multiprotein complex responsible for the synthesis of the cell wall peptidoglycan.
The C-terminal domain shows structural similarities with the transpeptidase domain of the penicillin-sensitive PBP2x and more generally with the penicillin-recognizing enzymes (b-lactamases of classes A, C or D [35] , E. coli PBP5 [36] , and the Streptomyces R61 [37] and K15 [38] DD-peptidases). The active-site serine 422 is located between two subdomains, one a five-stranded b sheet covered by helices, the other being all a helices. The Ser422 -Lys425 segment at the beginning of helix a C2 (the secondary-structural elements defined for class A blactamases will be used with subscript C to describe the transpeptidase domain) and the Ser480-Asp-Asn and Lys618-Thr-Gly-Thr motifs define the active-site cleft as in most active serine PBPs. The loop at the bottom of the cavity contains residues Gly537-Tyr-Gly-Gln-Gly and adopts the same conformation as in PBP2x. Downstream, the b C3 strand that bears the Lys618-Thr-Gly motif, the b C3 -b C4 connecting loop (residues 623 -632), is completely invisible in the electron density map of the three monomers. In PBP2x, this loop has three additional residues and defines one side of a long groove that stretches on both parts of the active site. The other side of the groove is delimited by residues 461 -465 which cover the Ser480-Asp-Asn motif. In PBP5fm, the groove is not as deep as in PBP2x and the residues bordering the active-site entry are different in both structures, maybe reflecting the specificity of the natural substrate of each enzyme. The main structural difference between PBP5fm and the b-lactamases or the LMM-PBPs is the insertion of three loops extending in the direction of the N-terminal domain. One of these loops (388 -410) is close to the poorly defined region 190-260 and a double hydrogen bond is formed between the Asn388 side chain and the Tyr265 backbone.
Structure of class B HMM-PBPs
Both PBP5fm and PBP2x belong to the class B HMMPBPs. All the members of this class share five common sequence motifs not directly involved in the enzymatic activity (motifs I-V: Arg173-Gly-Xaa-Xaa-Xaa-AspArg-Asn-Gly, Arg263-Xaa-Tyr-Pro-Xaa-Gly, Gly299-Xaa-Xaa-Gly-Xaa-Glu, Gly340-Xaa-Asp-Xaa-Xaa-XaaThr-Xaa-Asp-Xaa-Xaa-Xaa-Glu and Thr373-Gly-Asp (Glu)-Xaa-Leu-Ala-Xaa-Xaa-Xaa-Xaa-Pro-Ser-Xaa-Asp) [3] . These motifs are located at the interface between the N-and C-terminal domains ( fig. 2) . Motifs I and IV con- 
Interaction with penicillin
The electron density of the PBP5fm active site unambiguously reveals a covalent acyl-enzyme with benzylpenicillin ( fig. 3 A) . The thiazolidine ring and the carboxylate are well defined and the electron density is continuous between the active site serine hydroxyl group and the b-lactam carbonyl group. The side chain is easily traced in the electron density of monomer A but is less well defined in the other monomers. The benzylpenicillin conformation ( fig. 3 B) is similar to the one observed in the acyl-enzyme formed by benzylpenicillin and the Glu166-Asn inactive mutant of TEM1 class A b-lactamase [39] . The carbonyl oxygen lies in the oxyanion hole defined by the Ser422 and Thr618 main chain amine groups and the carboxylate is at hydrogen bond distance from Thr618 Og and Thr620 Og. The amide group of the benzylpenicillin side chain is wedged between Asn482 and the b C3 strand. In class A and class D b-lactamases, the carboxylate interacts with the guanidinium group of an arginine that can occupy different positions in the primary structure of these enzymes. The presence of such a guanidinium group in b-lactamases is favorable to acylation by b-lactams [40] . Acylation of PBP5fm is very slow (second-order rate constant k 2 /K = 20 M -1 s -1 ) [12] . It can proceed according to a two-step model where Lys425 abstracts a proton from the active-site serine hydroxyl group to promote the nucleophilic attack of the b-lactam carbonyl by the activated serine Og [39, 41] . The proton is subsequently back donated by Lys425 to the b-lactam nitrogen via Ser480. An alternative interpretation of the acylation mechanism relies upon a concerted one-step process where covalentbond formation between penicillin and the active-site serine Ser422 is concomitant with the transfer of the Ser422 proton directly to Ser480 and to the transfer of the Ser480 hydroxyl hydrogen to the b-lactam nitrogen [42] . Both charged Lys425 and Lys617 support the correct orientation of the Ser480 hydroxyl group. This explanation could prevail for all penicilloyl serine transferases including enzymes possessing a tyrosine residue instead of a serine in the second conserved active-site motif, such as class C b-lactamases. Both interpretations are in accordance with the distances between the active-site residues observed in PBP5fm. As for most PBPs, the deacylation step is extremely slow compared to the efficiency of the deacylation step in class A b-lactamases. In the latter, a glutamic acid residue in position 166 (bottom of the active site) is responsible for the high deacylation rate, by activating a conserved water molecule that attacks the acyl-enzyme carbonyl [43] . Though a water molecule is present in the PBP5fm active site at a position equivalent to the hydrolytic water molecule of class A b-lactamases, there is no counterpart to Glu166 that could be relevant to activate this molecule.
Low-level affinity
A low-level affinity for b-lactams is the main characteristic of the B1-PBPs. The second-order rate constant k 2 /K for the acylation of PBP2a from S. aureus by penicillin V is about 16 M -1 s -1 [44] . The corresponding values for PBP5fm from E. faecium strains vary from 15 to 24 M -1 s -1 and they are at least ten times lower for PBP5fm from highly resistant strains [12] . In comparison, a k 2 /K value of 58,000 M -1 s -1 has been reported for the acylation of PBP2x from a sensitive S. pneumoniae strain by benzylpenicillin [45] . The common motifs required to allow efficient acylation by penicillin are present in PBP5fm, with the exception of the guanidinium group found in b-lactamases that increases the efficacy of the acylation process, but this group is not essential for the acylation step [46] . The active-site cleft is delimited by the b C3 strand on one side, by residues 461 -465 on the opposite side, and the bottom of the cavity is covered with residues 537 -541. Among the residues surrounding the active-site groove, only Glu622 on the b C3 strand and Val465 on the opposite side can hinder the incoming antibiotic. In PBP2x, the mutation of Gln552 (equivalent to Glu622 in PBP5fm) into a glutamic acid results in a decreased affinity for benzylpenicillin by a factor of three [47] . Thus Glu622 could partially contribute to the low-level affinity of PBP5fm. On the other side of the groove, residues 461 -465 are part of a loop (451 -465) very well conserved in B1-PBPs, whereas the primary structure of this loop is different in the other classes of PBPs (figs 2 A, 4) . Arg464 might play a critical structural role. It is within hydrogenbonding distance from the backbone carbonyl oxygen of residues 446, 466 and 468, and is involved in a salt bridge with Asp481. Val465 points into the active site and its side chain is close to the benzylpenicillin thiazolidine ring. The distance between the valine side chain C g2 and the sulfur atom of the benzylpenicillin is about 3.5 Å. A backward movement of the valine and of the loop bearing this residue is perhaps necessary to allow access of benzylpenicillin into the active site. Comparison between the PBP2x structure and its adduct with cefuroxime (pdb codes 1QME and 1QMF [48] ) shows that a tryptophan, lying at a position equivalent to Val465, is slightly pushed away from the active site by cefuroxime and that the helix bearing the tryptophan is also somewhat displaced. In PBP5fm, the loop movement is accompanied by a shift of the Ser480-Asp-Asn loop via the Arg464-Asp481 salt bridge. Ser480 would then be too far away from the active-site serine to allow the proton shuttle between the active-site serine and the b-lactam nitrogen. According to this interpretation, the interaction between the 451 -465 loop and the second active-site motif, and more precisely the constraints induced by the Arg464 interactions, confer a great rigidity to this side of the groove that would be responsible for the low-level affinity of PBP5fm. Among the penicilloyl transferase enzymes, only B1-PBPs and class A b-lactamases have an aspartic acid in the second active-site element (Ser480-Asp-Asn). Nevertheless, the aspartic acid interactions as well as the enzyme structure around this residue are completely different in both types of enzyme. The strong interaction between Arg464 and Asp481 is thus typical of B1-PBPs. The bottom of the cavity is covered with residues 537 -541. These residues and the 530 -536 helix are well conserved in B1-PBPs whereas the whole 530 -541 sequence is different in other class B PBPs (fig. 4) . Nevertheless, no side chain position or particular interaction occurring in this region can easily be related to the lowlevel affinity of PBP5fm.
Highly resistant mutants
The protein described above is responsible for the high resistance to b-lactam antibiotics of the E. faecium D63r strain (MIC of penicillin = 70 mg/ml). The mechanism involved in the resistance is the overproduction of the protein [12] . The past two decades have seen the emergence of some clinical isolates highly resistant to ampicillin, not by means of PBP5fm overproduction but by a reduction of the protein affinity for the antibiotic. Following an analysis by Rybkine et al. [13] who studied a series of clinical isolates with various levels of resistance to ampicillin (well correlated with the resistance to benzylpenicillin), a first level of resistance is associated with PBP5fm overproduction but higher levels of resistance can be achieved by mutations of Met485 (fig. 4) or the insertion of an additional serine in position 466¢. MICs of ampicillin for strains retaining Met485 are not higher than 16 mg/ml (observed in four strains). Replacement of the methionine by threonine results in an MIC increase to values as high as 64 mg/ml (seven strains) while its mutation into alanine gives MICs ranging from 128 to 256 mg/ml (five strains). Met485 belongs to helix a C5 (three residues after the Ser480-Asp-Asn triad) and its side chain is located behind the Lys425 side chain. The removal of the bulky methionine side chain would set some free space, giving the lysine more conformational freedom and resulting in a less efficient acylation process. In a similar way, the substitution of Met426 by an isoleucine, as observed in the ampicillin-resistant strain 9439 [49] , could be responsible for the resistance of this strain to ampicillin. As Met426 is near Lys425, modification of its side chain could slightly destabilize the active site. Nevertheless, changing a methionine into an isoleucine only leads to minor steric modifications and can hardly account for an important reduction in the acylation of PBP5fm by ampicillin. Insertion of a serine in position 466¢ (residue 466 is also a serine) in the most resistant strains emphasizes the importance of the 451 -465 loop on the left-hand side of the active site. This insertion is associated with a twofold-increased MIC for penicillin (strains AR9, 6885 and H80721) and seems to be independent of Met485 mutations [13] . As mentioned above, Val465 is close to the thiazolidine ring of the penicilloyl moiety and the structure rigidity of the left side of the active-site cleft rests upon the Arg464 -Asp481 salt bridge. The insertion of a residue in position 466¢ may slightly displace Val465 inside the active site, reducing its accessibility for penicillin. The serine insertion would therefore affect substrate recognition.
Discussion
PBP5fm is a multimodular protein with two main domains. The C-terminal one, commonly named the penicillin-binding domain, is expected to be responsible for the DD-transpeptidase activity and is inhibited by b-lactam antibiotics. The function of the N-terminal domain is still unclear. However, the two domains seem to be interdependent. As the PBP5fm N-terminal domain is far from the penicillin-binding module active site (about 50 Å), the N-terminal module has been hypothesized to be necessary for correct folding of the C-terminal one. This assumption remains to be demonstrated but, presumably, a misfolded or unfolded truncated N-terminal domain may somehow modify the transpeptidase domain structure or interfere with its penicillin-binding ability. An interaction between the N-terminal domain and one or several other proteins remains the most attractive proposal. Since PBP5fm is deprived of the sequence motifs correlated with the transglycosylase activity of class A HMM-PBPs and seems, accordingly, to be unable to carry out this activity, the final step of the peptidoglycan synthesis may require its transpeptidase module to be near the transglycosylase domain of another protein. The recent finding that the transglycosylase domain of S. aureus PBP2, together with the PBP2a transpeptidase domain, is needed for the optimal expression of methicillin resistance [50] is supporting this hypothesis. The N-terminal extensions of the three representative B1-PBPs (PBP5fm, S. aureus PBP2a and B. subtilis PBP3) are of similar length and share common motifs which are missing in other subgroups of class B HMM-PBPs. Nevertheless, the homology between the primary structures of the three enzymes is lower in the globular region of the N-terminal module (from the anchor peptide to the first class B conserved motif, residues 39 -162) than in the rest of the molecule. This lends further support to the idea of an N-terminal module interacting with other proteins, since protein-protein interactions occurring in the supramolecular assembly involved in the late steps of peptidoglycan synthesis can be specific for each species. Yet, biological function of the N-terminal domain remains unclear and the validity of a model associating a normal PBP tranglycosylase activity and a rescue PBP transpeptidase activity to express b-lactam resistance remains to be demonstrated in enterococci. The reason why PBP5fm is naturally resistant to penicillin is not evident at first sight. Sequence alignments give supportive evidence that all B1-PBPs are structurally alike and probably play a similar functional role in peptidoglycan synthesis. The active-site region is surrounded by sequence elements (451-465, 530 -540) that are strongly conserved in B1-PBPs, while the sequence homology is lower in other regions. These sequence elements are not conserved in other classes of PBPs, in their primary structure and probably also in their tertiary structure, as shown by the comparison with the PBP2x three dimensional structure. Accordingly, the presence of Val465 near the binding site and the salt bridge Arg464-Asp481, characteristic of B1-PBPs, can be invoked as structural elements responsible for the low-level affinity for penicillin of these enzymes. PBP5fm mutations associated with highly resistant clinical isolates are the replacement of Met485 by threonine or alanine, potentially leading to a decrease of k 2 , and the insertion of a serine in position 466¢, which might in turn affect b-lactam recognition. The latter modification is found in the sequence of the most highly ampicillin resistant strains and seems to be an essential determinant in PBP5fm-mediated b-lactam resistance.
